|Articles|July 1, 2007

Volume 0

ADVANCIS CHANGES ITS CORPORATE NAME

Advancis Pharmaceutical Corp has changed its corporate name to Middlebrook Pharmaceuticals Inc. The company is the supplier of cephalexin (Keflex) capsules.

MiddleBrook Pharmaceuticals is a company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease.

In May 2007, the FDA accepted for review MiddleBrook?s new drug application for Amoxicillin PULSYS, a once-daily pulsatile-release formulation of amoxicillin for oral administration.

Articles in this issue

almost 19 years ago

Article

pharmacy TECHNOLOGY news

almost 19 years ago

Article

pharmacy TECHNOLOGY products

almost 19 years ago

Article

health-systems PRODUCT news

almost 19 years ago

Article

generic times product news

almost 19 years ago

Article

can you READ these Rxs?

almost 19 years ago

Article

A closer look at new FDA actions

almost 19 years ago

Article

can you READ these Rxs?

almost 19 years ago

Article

compounding HOTLINE

almost 19 years ago

Article

Is There Science in Quality?

almost 19 years ago

Article

Vaccines: Are You Protected?

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

$Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies$

ADVANCIS CHANGES ITS CORPORATE NAME

Articles in this issue

Related Content

The Rule of 72: Why Time Builds Wealth

The Innovations Center May Be Rolling Out Its Most Innovative Program Yet

Counseling Patients All Summer Long

Depression Common in Asthma, But Moderate to Severe Disease Worsens Outcomes

GLP-1s Are Associated With Reduced Asthma Exacerbation Risk in Nondiabetic Patients With Obesity

Latest CME

Personalizing Treatment in Relapsed/Refractory Multiple Myeloma: The Evolving Role of Antibody-Drug Conjugates and Bispecific Antibodies

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Beyond the Prescription: Tackling Social Isolation for Better Health (Pharmacy Technician Credit)

Understanding and Personalizing Chronic Obstructive Pulmonary Disease Diagnosis and Treatment

Directions in Pharmacy 2026

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

From Evidence to Access: Integrating SGLT2 Inhibitors Across the Cardiorenal-Metabolic Continuum

Identifying and Personalizing Iron Deficiency Anemia Treatment in Patients With Cancer

Iron Deficiency Anemia Treatment Considerations in Women’s Health

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Immunology Specialty Pharmacy Day of Education 2026

Improving Outcomes in Lipid Management: Aligning Managed Care Policy With Emerging Guideline Updates and Non-Statin Therapeutic Advances

The Educated Pharmacist: Using Patient Insights to Personalize Insulin Therapy and Prevent Clinical Inertia

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches

From Flares to Freedom: Navigating the Journey of Patients With Chronic Spontaneous Urticaria With Next-Generation Therapies

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Reducing the Treatment Burden in HIV Management: The Pharmacist’s Role in Long-Acting Injectable Adoption

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Exploring Immunotherapy Strategies in Endometrial Cancer

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

Managing Iron Replacement Therapies for Patients With Inflammatory Bowel Disease

Immunology Specialty Pharmacy Day of Education 2026

Stimulant Stewardship: A Pharmacist’s Guide to ADHD Prescribing During Drug Shortages

Redefining Metabolic Dysfunction-Associated Steatohepatitis Treatment: Managed Care Insights on New Therapies Targeting Metabolic Dysfunction

Not All Bispecifics Are Equal: Mechanism-Based Approaches to Selection and Management in Oncology Practice

Targeting Genomic Drivers to Optimize ROS1-Directed Therapy in NSCLC

Oncology Pharmacists Connect 2026

From Molecule to Medication: Integrating Menin Inhibitors in AML Practice

Enhancing Patient Outcomes in Metastatic Colorectal Cancer: Equipping Community, Veterans Affairs, and Oncology Pharmacists to Navigate Care in the Third-Line Setting and Beyond

Breast Cancer Day of Education 2026

Neuropsychiatry Day of Education 2026

Adapting to Advances in EGFR-Positive Non-Small Cell Lung Cancer Treatment: Critical Insights for Oncology Pharmacists

Outsmart the Algorithm: Combatting Misinformation at the Pharmacy Counter

Translating KDIGO Updates and Clinical Evidence Into Managed Care Decision-Making in IgA Nephropathy

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Beyond the Nasal Passage: Managing Chronic Rhinosinusitis With Nasal Polyps With Biologics and Pharmacist-Led Approaches

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Discipline Decoded: Navigating Pharmacy Law and Disciplinary Cases (Pharmacy Technician Credit)